Skip to content

ACN - 101321555 | ABN - 39101321555

Australasian Human Research Ethics Consultancy Services Pty Ltd (AHRECS)

AHRECS icon
  • Home
  • About Us
    • Consultants
    • Services
  • Previous Projects
  • Blog
  • Resources
  • Feeds
  • Contact Us
  • More
    • Request a Quote
    • Susbcribe to REM
    • Subscribe to VIP
Menu
  • Home
  • About Us
    • Consultants
    • Services
  • Previous Projects
  • Blog
  • Resources
  • Feeds
  • Contact Us
  • More
    • Request a Quote
    • Susbcribe to REM
    • Subscribe to VIP
Exclude terms...
Aboriginal and Torres Strait Islander
AHRECS
Analysis
Artificial Intelligence
Arts
Australia
Authorship
Belief
Beneficence
Big data
Biobank
Bioethics
Biomedical
Biospecimens
Breaches
Cartoon/Funny
Case studies
Clinical trial
Collaborative research
Conflicts of interest
Consent
Controversy/Scandal
Controversy/Scandal
Creative
Culture
Data management
Database
Dual-use
Essential Reading
Ethical review
Ethnography
Evaluative practice/quality assurance
First People
Fraud
Gender
Genetics
Good practice
Guidance
Honesty
HREC
Human research ethics
Humanities
Institutional responsibilities
International
Journal
Justice
Links
Media
Medical research
Merit and integrity
Methodology
Monitoring
New Zealand
News
Online research
Peer review
Performance
Primary materials
Principles
Privacy
Protection for participants
Psychology
Publication ethics
Questionable Publishers
Research ethics committees
Research integrity
Research Misconduct
Research results
Researcher responsibilities
Resources
Respect for persons
Sample paperwork
sd
Serious Adverse Event
Social Science
SoTL
Standards
Supervision
Training
Vulnerability
Young people
Exclude news

Sort by

Human Research Ethics Research Integrity

The Lancet changes editorial policy after hydroxychloroquine Covid study retraction – The Guardian (Melissa Davey | September 2020)

Posted by Dr Gary Allen in Research Integrity on November 13, 2020
Keywords: Clinical trial, Controversy/Scandal, Data management, Institutional responsibilities, International, Journal, Medical research, Merit and integrity, Publication ethics, Research integrity, Research Misconduct, Research results
Dictionary definition of misconduct

New policy comes after serious quality control questions were raised about the data relied on by a study in the medical journal

One of the world’s leading medical journals, the Lancet, has reformed its editorial policies following a shocking case of apparent research misconduct involving the study of hydroxychloroquine as a treatment for Covid-19.

We are surprised this prestigious journal wasn’t taking this precaution before.

In May, the Lancet published a peer-reviewed study about the controversial drug hydroxychloroquine, which concluded Covid-19 patients who received the drug were dying at higher rates and experiencing more heart-related complications than other virus patients.

The large observational study analysed data purported to be from nearly 15,000 patients with Covid-19 who received the drug alone or in combination with antibiotics, comparing this data with 81,000 controls who did not receive the drug.

Read the rest of this discussion piece

Related Reading

The Surgisphere Scandal: What Went Wrong? – The Scientist (Catherine Offord | October 2020)

The need for rigor: Retractions can damage public trust – HealthyDebate (Pippa Wysong | July 2020)

(UK) Study: Hydroxychloroquine had no benefit for hospitalized Covid-19 patients, possibly closing door to use of drug – STAT News (Matthew Herper | June 2020)

Publication by association: the Covid-19 pandemic reveals relationships between authors and editors (Papers: Clara Locher, et al | July 2020)

(EU) French hydroxychloroquine study has “major methodological shortcomings” and is “fully irresponsible,” says review, but is not being retracted – Retraction Watch (Ivan Oransky | July 2019)

Covid-19 studies based on flawed Surgisphere data force medical journals to review processes – The Guardian (Melissa Davey | June 2020)

Column: How a retracted research paper contaminated global coronavirus research – Los Angles Times (Michael Hiltzik | June 2020)

Just How Historic Is the Latest Covid-19 Science Meltdown? – WIRED (Adam Marcus & Ivan Oransky | June 2020)

(US) FDA revokes emergency use ruling for hydroxychloroquine, the drug touted by Trump as a Covid-19 therapy – STAT (Lev Facher | June 2020)

The Lancet has made one of the biggest retractions in modern history. How could this happen? – The Guardian (James Heathers | June 2020)

Virus Pushes Science And Its Controversies Centre Stage – Barrons (Stéphane ORJOLLET | May 2020)

(France) French hydroxychloroquine-COVID-19 study withdrawn – Retraction Watch (Ivan Oransky | May 2020)

(France) He Was a Science Star. Then He Promoted a Questionable Cure for Covid-19 – New York Times Magazine (Scott Sayare | May 2020)

Hydroxychloroquine-COVID-19 study did not meet publishing society’s “expected standard” – Retraction Watch (Adam Marcus | April 2020)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Links

Complaints against Research Ethics Monthly

Request a Takedown

Submission Guidelines

About the Research Ethics Monthly

About subscribing to the Research Ethics Monthly

A diverse group discussing a topic

Random selected image from the AHRECS library. These were all purchased from iStockPhoto. These are images we use in our workshops and Dr Allen used in the GUREM.

Research Ethics Monthly Receive copies of the Research Ethics Monthly directly
by email. We will never spam you.

  • Home
  • Services
  • About Us
  • Contact Us
Menu
  • Home
  • Services
  • About Us
  • Contact Us
  • Company
  • Terms Of Use
  • Copyright
  • Privacy Policy
  • Disclaimer
Menu
  • Company
  • Terms Of Use
  • Copyright
  • Privacy Policy
  • Disclaimer
  • Support
  • Contact Us
  • Site Map
Menu
  • Support
  • Contact Us
  • Site Map

Australasian Human Research Ethics Consultancy Services Pty Ltd (AHRECS)

Facebook-f
Twitter
Linkedin-in